AiCure is a patient-centric eClinical trials management platform company that empowers life science and healthcare organizations to unlock valuable unbiased, computer-vision driven insights to optimize personalized care.

Adam Hanina

Laura Shafner

AiCure

Avegen provides digital health solutions aimed at improving patient management for healthcare providers and pharmaceutical companies. Self-described as empowering patients to manage their health through customizable apps.

Avegen

OpenDBM

AiCure is an AI and advanced data analytics company that monitors patient behavior and enables remote patient engagement in clinical trials. AiCure improves predictability of study timelines, reduces costs and accelerates timelines through remote patient engagement and assessments, including measuring digital biomarkers and real-time monitoring of patient dosing. Founded in 2010 and funded by the National Institutes of Health (NIH) and leading institutional investors, AiCure has more than 65 issued patents and works with global clients in over 30 countries. AiCure is globally recognized and is a recipient of the Scrip Award, AI 100 and Digital Health 150. For more information, please visit www.aicure.com. 

New Leaf Venture Partners

Palisades Growth

Biomatics Capital Partners

Pritzker Group Venture Capital

Singtel Innov8

SpringRock Ventures

Tribeca Venture Partners

Accelmed

Silicon Valley Bank

Asahi Kasei

Today is the start of #OCTWestCoast. Make sure to stop by booth #83 and visit with Sondra Pepe and Amy J Ford, MA ORGL from AiCure to learn how our smartphone-based AI platform leverages predictive analytics to manage risk in your clinical research.

The 16th Annual Outsourcing in Clinical Trials West Coast is a collaborative environment where pharma & biotech leaders can find solutions to current challenges through innovations and partnerships.

#digitalinnovation 

The 15th Annual #SCOPESummit is this Sunday, February 11th in Orlando, Florida. AiCure will be attending and we look forward to connecting with you.

The Scope Summit aims to drive innovation in clinical trials and digital health.  Execution of this vital work requires collaboration, innovation, and strategic decision-making.

Please connect with one of our team members to learn more about how AiCure uses a smartphone-based AI platform to support Medication Adherence and Dosing Support and gain novel patient insights in clinical trials.

Joshua Wilson
Amanda Paley
Greg Zak

Learn more about Scope Summit: https://lnkd.in/g9N7SgA

#SCOPE2024 #clinicaltrials 

Join AiCure at booth 83 during #OCTWestCoast, taking place on February 6-7, 2024, in Burlingame, California. 

Our team will showcase how our Artificial Intelligence smartphone-based platform supports Medication Adherence and Dosing Support, providing novel patient insights. 

Connect with Sondra Pepe and Amy J Ford, MA ORGL to schedule a meeting and learn more. 

For additional details about OCT West Coast, visit the event's official website: https://lnkd.in/guBVpr77

#clincaltrials

AiCure has announced new funding, new patents awarded, and new members of the leadership team. 

"AiCure's innovative software and technology are designed to improve patient engagement and sponsor insights in clinical trials, making it a valuable player in the life sciences industry. With its continued growth and focus on innovation, AiCure is poised to make a lasting impact on the future of clinical research."

Read the full press release: https://lnkd.in/eyBSZ9yT

#growth #clinicalresearch 

"Research into substance use disorder treatments is complex and evolving, uniquely shaped by scientific advancements, societal attitudes, and the changing nature of substance use disorders themselves."

AiCure's latest blog covers how our smartphone-based platform was used in a Substance Use Disorder (SUD) trial to improve treatment adherence and collect daily reports on drug and alcohol use. This approach offers several advantages over traditional methods, making it a powerful tool for SUD clinical trial teams.

Read the full blog here: https://lnkd.in/d92dEARE

#ClinicalTrials #MedicationAdherence #HealthcareInnovation #substanceusedisorder 

Metric
Company Name	AiCure	Avegen
Symbol
MSH ID	COM:AICURE	COM:AVEGENHEALTH
Market	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Healthcare Technology	Health Technology
Country	US	GB
Stage
Employee Count	73
Website	aicure.com	avegenhealth.com
LinkedIn	aicure	avegen
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2.19K	558
Web Traffic Growth	-0.04	-0.53
Valuation
Raised Capital	12M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:AICURE

AiCure

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue